Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

Autor: Mehl Erika, Kenney Challayne, Santos Jennifer L, McKinney Steven, Köbel Martin, Kalloger Steve, Klausen Christian, Prentice Leah M, Gilks C Blake, Leung Peter, Swenerton Ken, Huntsman David G, Aparicio Samuel AJ

Publikováno v: BMC Medicine, Vol 5, Iss 1, p 33 (2007)

Abstract Background Kisspeptins and their G-protein coupled receptor, GPR54 are required for GnRH release and have been associated with anti-metastatic tumour cell behaviour in model systems. The latter might suggest that their overexpression would b

Externí odkaz: https://doaj.org/article/186d7ca9fa664cf28e956444fca9ebb4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Potential underdosing of carboplatin in gynecological malignancies

Autor: de Lemos*, Mário L., Hamata, Linda, Conklin, James, Swenerton, Ken

Publikováno v: In Gynecologic Oncology 2006 102(3):599-599

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Autor: Dark GG; MBBS, MRCP, ILTM, Department of Medical Oncology, University of Newcastle, Westgate Rd, Newcastle upon Tyne, NE4 6BE, United Kingdom. graham.dark@ncl.ac.uk, Calvert AH, Grimshaw R, Poole C, Swenerton K, Kaye S, Coleman R, Jayson G, Le T, Ellard S, Trudeau M, Vasey P, Hamilton M, Cameron T, Barrett E, Walsh W, McIntosh L, Eisenhauer EA

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2005 Mar 20; Vol. 23 (9), pp. 1859-66. Date of Electronic Publication: 2005 Feb 07.